Skip to Main Content

Paper Details

Conventional and Unconventional Therapeutic Strategies for Sialidosis Type I.
J Clin Med
11
2020
NEU1, PPCA, Sialidosis, Sialidosis Type I, amino acid, fibroblasts, lysosomal storage disease, mouse, mutant NEU1, oligosacchariduria, orphan diseases, patients, primary fibroblasts, recombinant protective protein/cathepsin A, sialidosis, sialidosis type I, sialo, type I sialidosis
Author NameAffiliation
Cynthia J TifftOffice of the Clinical Director & Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health (NHGRI)
Cynthia J TifftOffice of the Clinical Director & Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health (NHGRI)
Camilo ToroNational Human Genome Research Institute, National Institutes of Health
  • 1 - 3

Datasets

Release 1.2